合并髂动脉闭塞性疾病与主动脉瘤对开放手术修复的影响
该回顾性研究比较了1994至2017年间接受开放腹主动脉瘤修复的1087例患者,其中981例标准腔内修复,106例需主股动脉旁路。结果显示主股动脉旁路组女性更多、合并症更高、主动脉直径更小,30天并发症和再干预率更高,5年生存率更低,但30天死亡率和主要并发症无差异。多因素分析表明患者和动脉瘤特征而非修复类型是独立预测因素。
要点
- 主股动脉旁路组30天并发症(38.7% vs 24.8%)和再干预率(12.3% vs 4.6%)更高。
- 30天死亡率和主要并发症两组无差异,AFB可作为EVAR的替代选择。
核心结论
- 需主股动脉旁路的开放腹主动脉瘤修复患者术前合并症更多、术后并发症和再干预率更高、住院时间更长、5年生存率更低,但30天死亡率和主要并发症与标准修复相当,因此AFB是晚期髂动脉闭塞性疾病患者替代EVAR的 attractive 选择。
研究设计与样本
- 回顾性队列研究,使用前瞻性维护数据库,纳入1994至2017年连续1087例开放腹主动脉瘤修复患者,其中981例标准腔内修复(681例管状移植物,300例主髂动脉),106例主股动脉旁路。
关键数值与推荐
- 多因素回归分析确定年龄、合并症和动脉瘤特征而非修复类型是30天再干预和5年死亡率的独立预测因素。
临床怎么用
- 对于合并严重髂动脉闭塞性疾病的腹主动脉瘤患者,主股动脉旁路开放修复虽然并发症和再干预率较高,但30天死亡率和主要并发症与标准修复相当,可作为EVAR的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Severe aortoiliac occlusive disease is a relative contraindication for endovascular aneurysm repair, owing to an association with high stent graft-related complication and reintervention rates in this population. Open AAA repair requiring aortofemoral bypass (AFB), however, may represent a unique population with differing outcomes from standard open repair. We sought to compare the demographic and procedural characteristics, as well as outcomes of patients undergoing standard intra-abdominal repairs (STD) versus those requiring AFB. METHODS: Using a prospectively maintained database, we retrospectively identified patients who underwent open AAA repair from 1994 to 2017. A total of 1087 consecutive cases were performed consisting of 981 STD (681 tube graft, 300 aortoiliac) and 106 AFB cases. Demographics, procedural data, postoperative complications, and long-term survival were analyzed. RESULTS: The AFB cohort had more women (39.0 vs 22.8%; P = .001) and higher rates of hypertension (81.1 vs 69.8%; P = .015), chronic obstructive pulmonary disease (28.3 vs 17.4%; P = .006), and smoking (50.9 vs 36%; P = .002). The AFB group had smaller mean aortic (5.22 vs 5.77 cm; P = .001) and graft (17.08 vs 18.2 mm; P = .001) diameters. Proximal clamp position and blood loss were equivalent, although total anesthesia time was longer (295 vs 234 minutes; P = .001) in the AFB cohort. Overall 30-day postoperative morbidity (38.7 vs 24.8%; P = .002) was higher in the AFB group. Specifically, postoperative renal insufficiency (8.2 vs 3.4%; P = .032), wound infection (5.7 vs 1.2%; P = .005), and hematoma/seroma (5.7 vs 1.2%; P = .003) were more likely. Hospital length of stay was longer for AFB (11.9 vs 9.9 days; P = .007). The 30-day mortality (0.9% AFB vs 1.8% STD; P = .50) and major morbidity (17 vs 11.5%; P = .10) did not differ. Reintervention rate within 30 days of the initial surgery (12.3 vs 4.6; P = .001) and overall (33 vs 18.9%; P = .001) was higher in the AFB group. Long-term survival was lower in the AFB group (5-year survival: 63.1% AFB vs 71.9% STD; hazard ratio 0.76, log-rank P = .047). Multivariate regression analysis identified age, comorbid conditions, and aneurysm characteristics-rather than repair type-as independent predictors of 30-day reintervention and mortality at 5 years. CONCLUSIONS: Patients requiring AFB for AAA owing to associated iliac occlusive disease have more preoperative comorbidities, postoperative complications, a longer length of stay, reintervention rates and shorter 5-year survival. Patient and aneurysm characteristics rather than surgical repair type appear to be responsible for these differences. Nevertheless, 30-day mortality and major morbidity were comparable, making AFB an attractive alternative to endovascular aneurysm repair in patients with advanced iliac occlusive disease.
引用
- Lotto CE, Sharma G, Walsh JP, et al. The impact of combined iliac occlusive disease and aortic aneurysm on open surgical repair. J Vasc Surg. 2019. PMID: 31727458. doi:10.1016/j.jvs.2019.08.249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。